Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 70 Rectal Neoplasms 29 Colonic Neoplasms 28 Carcinoma, Hepatocellular 26 Neoplasm Metastasis 15 Stomach Neoplasms 12 Pancreatic Neoplasms 7 Cholangiocarcinoma 6 Adenocarcinoma Of Esophagus 6 Esophageal Neoplasms 5 Recurrence 4 Liver Neoplasms 4 Biliary Tract Neoplasms 4 Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Peritoneal Neoplasms 2 Neoplastic Cells, Circulating 2 Gastrointestinal Neoplasms 2 Colorectal Cancer Metastatic 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Adenocarcinoma 2 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma 1 Operable T2-3N+M0 Rectal Cancer (Stage III) 1 Oligometastatic Gastric Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neuropathy, Painful 1 Neuralgia 1

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locally-advanced Rectal Cancer × Folfox protocol × Clear all

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡